(Q43692320)

25 November 2017

title

2-methoxyestradiol blocks cell-cycle progression at G(2)/M phase and inhibits growth of human prostate cancer cells (English)

1 reference

25 November 2017

Kumar AP

1

1 reference

25 November 2017

Garcia GE

series ordinal

2

1 reference

25 November 2017

Slaga TJ

series ordinal

3

1 reference

25 November 2017

publication date

1 July 2001

1 reference

25 November 2017

published in

Molecular Carcinogenesis

1 reference

25 November 2017

volume

31

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

111-124

1 reference

25 November 2017

cites work

Cancer statistics, 1999.

1 reference

Target to apoptosis: a hopeful weapon for prostate cancer

21 January 2018

1 reference

Estrogens and prostatic disease. International Prostate Health Council Study Group

21 January 2018

1 reference

Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol.

21 January 2018

1 reference

Cloning of a novel receptor expressed in rat prostate and ovary

21 January 2018

1 reference

Estrogen receptor expression in prostate cancer and premalignant prostatic lesions

21 January 2018

1 reference

Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats

21 January 2018

1 reference

Generation and reproductive phenotypes of mice lacking estrogen receptor beta

21 January 2018

1 reference

PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo .

21 January 2018

1 reference

The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells

21 January 2018

1 reference

The mammalian metabolite, 2-methoxyestradiol, affects P53 levels and apoptosis induction in transformed cells but not in normal cells

21 January 2018

1 reference

Superinduction of wild-type p53 protein after 2-methoxyestradiol treatment of Ad5p53-transduced cells induces tumor cell apoptosis

21 January 2018

1 reference

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

21 January 2018

1 reference

Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining

21 January 2018

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

Regulation of rat ornithine decarboxylase promoter activity by binding of transcription factor Sp1.

21 January 2018

1 reference

Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1.

21 January 2018

1 reference

Inhibition of the catechol-O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by catecholamine: implications for the mechanism of estrogen-induced carcinogenesis.

21 January 2018

1 reference

Induction of human breast cancer cell apoptosis from G2/M preceded by stimulation into the cell cycle by Z-1,1-dichloro-2,3-diphenylcyclopropane.

21 January 2018

1 reference

Morphological and biochemical characterization and analysis of apoptosis

21 January 2018

1 reference

Caspase structure, proteolytic substrates, and function during apoptotic cell death

21 January 2018

1 reference

Principles of CDK regulation

21 January 2018

1 reference

Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis

21 January 2018

1 reference

Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase

21 January 2018

1 reference

Universal control mechanism regulating onset of M-phase

21 January 2018

1 reference

Regulation of p53 downstream genes.

21 January 2018

1 reference

Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition

21 January 2018

1 reference

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

p53 oncogene mutations in three human prostate cancer cell lines

21 January 2018

1 reference

p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.

21 January 2018

1 reference

Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53

21 January 2018

1 reference

Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site

21 January 2018

1 reference

Functional synergy between the transcription factor Sp1 and the estrogen receptor

21 January 2018

1 reference

The cell cycle and cancer

21 January 2018

1 reference

Apoptosis in the pathogenesis and treatment of disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.1046

1 reference

25 November 2017

1 reference